Search
for
Sort by
Research 661–690 of 877
- A Multimodal Approach to Facial Rejuvenation—Integrating HA Fillers, Collagen Stimulators, Botulinum Toxin and Energy-Based Devices for Optimal Patient Outcomes
- Brimonidine Beyond a Single Specialty: Pharmacological Profile, Dermatologic Applications, and Advances in Drug Delivery Systems
- Using the Mechanisms of Action Involved in the Pathogenesis of Androgenetic Alopecia to Treat Hair Loss
- Serotonin activates dermal papilla cells and promotes hair growth
- Dynamic changes of gut and skin microbiota in pancreatic cancer-induced skin injury
- Understanding the Intricate Pathophysiology of Psoriasis and Related Skin Disorders
- Pathogenesis of Alopecia Areata and Vitiligo: Commonalities and Differences
- Exploring the Gut Microbiome and Metabolome in Individuals with Alopecia Areata Disease
- Placental mRNA Expression of Neurokinin B Is Increased in PCOS Pregnancies with Female Offspring
- Systematic review: Impact of stem cells-based therapy, and platelet-rich plasma in hair loss and telogen effluvium related to COVID-19
- Oral Combination Treatment of Gefitinib (IressaTM) and Sasam-Kyeongokgo: Synergistic Effects on the NCI-H520 Tumor Cell Line
- Clinical Findings, Response to Steroid Treatment, and Recurrence Rate in Alopecia Areata Patients with or without a Nonsynonymous Variant of Coiled-Coil Alpha-Helical Rod Protein 1
- A volar skin excisional wound model for <i>in situ</i> evaluation of multiple-appendage regeneration and innervation
- Alopecia Areata in Latin America: Where are We and Where are We Going?
- Alopecia Areata, triggered by psychological stress and successfully treated with a Janus kinase inhibitor. Case report
- Insulin resistance as risk factor for the development of type 2 diabetes mellitus: a systematic approach
- COVID-19 Can Exacerbate Pattern Hair Loss and Trigger Telogen Effluvium - The Role of Proteoglycan Replacement Therapy with Nourkrin® in Clinical Treatment of COVID-19 Associated Hair Loss
- Genome-wide association study in alopecia areata implicates both innate and adaptive immunity
- Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial
- Adult female acne: a guide to clinical practice
- Pathophysiological mechanisms implicated in postpartum depression
- Lack of Evidence for Sprouting of Aβ Afferents into the Superficial Laminas of the Spinal Cord Dorsal Horn after Nerve Section
- The dark art of light measurement: accurate radiometry for low-level light therapy
- Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases
- Efficacy and safety of methotrexate in alopecia areata
- Genetic Basis of Alopecia Areata
- Scalp Pruritus: Review of the Pathogenesis, Diagnosis, and Management
- Photobiomodulation for the management of alopecia: mechanisms of action, patient selection and perspectives
- Neurosteroids Are Endogenous Neuroprotectants in an Ex Vivo Glaucoma Model
- Prevention and treatment of alopecia areata with quercetin in the C3H/HeJ mouse model